Cargando…

First-in-human Phase 1 CRISPR Gene Editing Cancer Trials:Are We Ready?

A prospective first-in-human Phase 1 CRISPR gene editing trial in the United States for pa-tients with melanoma, synovial sarcoma, and multiple myeloma offers hope that gene editing tools may usefully treat human disease. An overarching ethical challenge with first-in-human Phase 1 clinical trials,...

Descripción completa

Detalles Bibliográficos
Autores principales: Baylis, Françoise, McLeod, Marcus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5769084/
https://www.ncbi.nlm.nih.gov/pubmed/29173170
http://dx.doi.org/10.2174/1566523217666171121165935

Ejemplares similares